Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
CHICAGO, July 25, 2017 -- John Cherf, MD, MPH, MBA, chief of orthopedics at Advocate Illinois Masonic Medical Center, and Julie Schulz, MD, MPH, Procured Health vice president, will present “Leveraging Evidence-Based Medicine to Reduce Clinical Costs and Improve Outcomes” on Wednesday, July 26, at the AHRMM17 Conference in Washington, D.C.
“Collaboration between hospitals and physicians is essential to improving cost, quality and outcomes,” Dr. Cherf said. “Using reliable evidence to drive discussions about device selection and new technology adoption ensures that the conversation is objective, vendor neutral and focused on providing the best care possible.”
During their presentation, Dr. Cherf and Dr. Schulz will highlight:
- How taking an evidenced-based approach can guide clinical conversations around product selection and action
- Innovative tips and best practices to better engage physicians in discussions about device selection
- Advocate Health Care's physician-led, patient-centered approach to reducing clinical variation in spine care
“In one year alone, U.S. health systems overspend on medical supplies and devices by an estimated $35 billion, due to both inflated prices and overuse of premium products,” Dr. Schulz said. “Many hospitals believe that if they limit device selection, physicians will choose to practice elsewhere, but Procured Health’s research doesn’t support this belief. Physicians are eager to use products that improve care, as supported by clinical evidence.”
Hosted by the Association for Healthcare Resources and Materials Management, AHRMM17 is the leading education event for individuals and organizations working to improve cost, quality and outcomes in healthcare supply chain.
About Procured Health
Procured Health is at the forefront of helping health systems achieve the best clinical outcomes at an optimal cost by making clinical evidence accessible and actionable. Providers across the U.S. rely on Procured Health's technology platform to make better decisions on spend and usage of medical devices, supplies, and drugs.
For more information, visit ProcuredHealth.com, find us on LinkedIn, follow @ProcuredHealth on Twitter and like us on Facebook.
Procured Health [email protected] (312) 300-7899
